The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
K. C. Kent Lloyd is a professor in the Department of Surgery, School of Medicine, director of the Mouse Biology Program and NAMs Testing Center and associate director of the Comprehensive Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results